Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of Directors
Senior management
Our history
Research and development
Technology platform
Therapeutic areas
Pipeline
Scientific papers and presentations
Partnering
Our approach
Our partnerships
Investors
Financial reports and presentations
Share information
Analyst coverage
Major shareholders
Financial calendar
Corporate governance
Corporate governance statements
Dividend policy
Annual general meeting
Articles of association
Safe harbour statement
Whistleblower policy
Risk management
Investor relations policy
ESG
Email alerts
Newsroom
Press Releases
Image library
Glossary
Email alerts
Careers
Search
Investors
Financial reports and presentations
Newest first
Oldest first
Presentations
Financial reports
Webcasts
Search
Reset
07/11/2022
Credit Suisse 31st Annual Healthcare conference, 2022 – presentation
26/10/2022
Nykode Therapeutics Announces Presentation of Positive Immunogenicity Results from Phase 1/2a Study of VB10.NEO, an Individualized Therapeutic Cancer Vaccine, at the Neoantigen-Based Therapies Summit
27/09/2022
Initial Results from the Phase 1/2 Trial of the T Cell SARS-CoV-2 Vaccine Candidate VB10.2210 – presentation
13/09/2022
H.C. Wainwright 24th Annual Global Investment Conference, September 13, 2022 – presentation
13/09/2022
H.C. Wainwright 24th Annual Global Investment Conference, September 13, 2022 – webcast
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer
